Clinical Trial Results:
A phase II, 12-week randomized, double-blind, triple dummy, parallel group, placebo-controlled, dose range finding study to evaluate safety, tolerability and efficacy of revamilast in patients with chronic persistent asthma.
Summary
|
|
EudraCT number |
2011-000270-57 |
Trial protocol |
GB CZ |
Global completion date |
08 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Dec 2016
|
First version publication date |
30 Dec 2016
|
Other versions |
|
Summary report(s) |
Synopsis GRC 4039-204 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.